Open house drug discount agreements Liraglutid, ATC A10BJ02

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline May 05, 2027 · 249 days left·Open·Supplies·Framework

Inscrivez-vous pour sauvegarder Open documents

Structured notice only

Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Liraglutid, ATC A10BJ02

50/100

Score d'opportunité

Needs reviewLow complexity

SuppliesFrameworkOpen

Pourquoi ce score ?

Opportunité

50 / 100

Complexité

30 / 100

Facteurs de risque

Submission requirements are strict: paper submissions must be in duplicate original, and electronic submissions require...

The open-house model is not subject to procurement law, but recourse is to social courts rather than procurement tribun...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Aperçu

Moderate opportunity

Faits clés

Framework procurement
Supplies contract
1 lot
Duration until Jun 2027
Enter into a non-exclusive discount agreement with AOK Bayern for Liraglutid (ATC A10BJ02)
Supply the pharmaceutical product under the agreed discount terms

Afficher le résumé complet

This is an open-house model for non-exclusive drug discount agreements on Liraglutid (ATC A10BJ02) offered by AOK Bayern. All eligible pharmaceutical companies can participate. The contract runs from 01.07.2025 to 30.06.2027, with a rolling submission deadline until 05.05.2027. No selection is made; all qualifying applicants receive a contract. The procedure is not subject to procurement law.

Risques

Submission requirements are strict: paper submissions must be in duplicate original, and electronic submissions require...

The open-house model is not subject to procurement law, but recourse is to social courts rather than procurement tribun...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

Must be a pharmaceutical company (pharmazeutischer Unternehmer)

Administrative

Submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
Submit the signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'

Les exigences peuvent être incomplètes.

Acheteur

Nom

AOK Bayern - Die Gesundheitskasse

Localisation

München, DEU

[email protected]

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open house drug discount agreements Liraglutid, ATC A10BJ02

Non-exclusive discount agreement for the active substance Liraglutid, ATC code A10BJ02. The contract is open to all pharmaceutical companies that meet the eligibility criteria.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Jun 2025 - Jun 2027

Catégorie

Pharmaceutical products

Date limite

Deadline May 05, 2027

Détails de la procédure

Date de publication: 15 May 2025
Langues: German

Métadonnées de référence

Base juridique: 32014L0024

Identifiants de référence

ID de l'appel d'offres: 315079-2025

Documents (2)

Document de consultation 1 Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3